黑料网

Oral mucosa; Immune surveillance; Mucosal immunity; Dendritic cells; Mucosal-associated lymphoid tissue (MALT); Innate immunity; Adaptive immunity; Oral infections

Introduction

The oral mucosa serves as a primary interface between the external environment and the body, presenting a unique challenge for immune surveillance. This mucosal surface, which includes the oral cavity, gums, and tongue, is continually exposed to a variety of pathogens, antigens, and environmental factors [1]. To effectively protect against these threats, the oral mucosa employs a sophisticated immune system that balances tolerance and defense [2]. The oral mucosa is equipped with both innate and adaptive immune mechanisms. Innate immunity is the first line of defense and includes physical barriers such as the mucosal epithelial layer and antimicrobial peptides. Additionally, innate immune cells, including dendritic cells and macrophages, play a crucial role in recognizing and responding to pathogens [3]. These cells are strategically positioned in the oral mucosa to detect and initiate immune responses against invading microorganisms. Mucosal-associated lymphoid tissue (MALT) within the oral mucosa further enhances immune surveillance [4]. MALT includes structures such as tonsils and Peyer's patches, which are crucial for the activation and coordination of immune responses [5]. The interaction between these tissues and local immune cells facilitates a robust and tailored immune response to oral pathogens [6]. Furthermore, the dynamic interaction between epithelial cells and immune cells in the oral mucosa contributes to the regulation of immune responses. Epithelial cells not only act as a physical barrier but also produce cytokines and chemokines that influence immune cell behavior [7]. This interplay between innate and adaptive immune components is essential for maintaining oral health and preventing disease.

Results

Recent studies have elucidated several key findings regarding immune surveillance and response in the oral mucosa. Dendritic cells, specifically Langerhans cells in the epithelium, play a pivotal role in antigen capture and presentation. These cells are adept at processing oral antigens and presenting them to T cells in the local lymph nodes, initiating a targeted immune response. Mucosal-associated lymphoid tissue (MALT), particularly the tonsils, has been shown to be instrumental in the immune response to oral pathogens. Research highlights the significant role of tonsillar lymphocytes in generating systemic and local immune responses. Additionally, the expression of pattern recognition receptors (PRRs) on mucosal cells facilitates the detection of microbial components, triggering innate immune responses and influencing adaptive immunity. Studies have also demonstrated the importance of epithelial cells in orchestrating immune responses. Epithelial cells produce various cytokines and chemokines that recruit and activate immune cells, influencing the overall immune response in the oral mucosa. This interaction between epithelial cells and immune cells is crucial for maintaining the balance between tolerance and immunity.

Discussion

The mechanisms of immune surveillance and response in the oral mucosa are complex and involve a delicate balance between immune protection and tolerance. The role of dendritic cells and MALT in antigen presentation and immune activation is well established, highlighting their importance in oral immunity. However, recent research has also emphasized the significant contribution of epithelial cells in regulating immune responses [8]. The production of cytokines and chemokines by epithelial cells not only recruits immune cells but also modulates their function, illustrating the dynamic nature of mucosal immunity. Despite the advances in understanding oral mucosal immunity, several questions remain unanswered [9]. For instance, the precise mechanisms by which epithelial cells influence immune responses and the impact of various environmental factors on mucosal immunity require further investigation. Additionally, the interplay between local immune responses and systemic immunity in the context of oral diseases remains an area of active research. Understanding these mechanisms has important implications for clinical practice, particularly in the prevention and management of oral infections and autoimmune disorders [10]. Future research should focus on elucidating the detailed interactions between different immune components and identifying potential therapeutic targets for enhancing oral mucosal immunity.

Conclusion

The oral mucosa is a critical site for immune surveillance, equipped with a sophisticated network of innate and adaptive immune mechanisms. The roles of dendritic cells, mucosal-associated lymphoid tissue (MALT), and epithelial cells in immune surveillance and response are fundamental to maintaining oral health and preventing disease. Dendritic cells are essential for antigen capture and presentation, while MALT structures such as tonsils are crucial for generating targeted immune responses. Epithelial cells play a significant role in regulating these immune responses through cytokine and chemokine production. Despite the progress in understanding oral mucosal immunity, ongoing research is needed to address remaining questions and explore the implications for clinical practice. A deeper understanding of the mechanisms underlying immune responses in the oral mucosa will enhance our ability to prevent and manage oral infections and autoimmune conditions. As research continues to evolve, it is crucial to integrate these insights into clinical practice to improve patient outcomes and advance the field of oral immunology. Future studies should focus on elucidating the complex interactions between immune cells and epithelial cells, as well as exploring novel therapeutic strategies to modulate mucosal immunity. This comprehensive understanding will ultimately contribute to better management of oral health and disease.

1. Brandtzaeg P, Farstad N, Johansen E, Morton C, Norderhaug N, et al. (1999) . Immunol Rev 171: 45-87.
2. Paredes F (2021) . Cancer Lett 502: 133-142.

, , Crossref

3. Benassi B (2006) . Mol Cell 21: 509-519.

, , Crossref

4. Ruddle H, Akirav M (2009) . J Immunol 183: 2205-2212.
5. Lazado CC (2014). Fish Shellfish Immunol 39: 78-89.

, , Crossref

6. Cheng (2021) . Front nutr 30: 686752.

, , Crossref

7. Macpherson AJ, Mcoy D, Johansen F, Brandtzaeg P (2008) . Mucosal Immunol 1: 11-22.
8. Shi H, Han X, Jiang N, Cao Y, Alwalid O, et al.(2020) . Lancet Infect Dis 20: 425-434.

, , Crossref

9. Wu T, Leung K, Leung M (2020) . The Lancet 395: 689-697.

, , Crossref

10. Don K (2004) . Seminars in Dialysis, 17: 432-437.

, , Crossref